AI assistant
VOLITIONRX LTD — Director's Dealing 2015
Aug 28, 2015
34395_dirs_2015-08-28_bd6afe56-b91e-4402-b186-7d6b084b34ff.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2015-08-18
Reporting Person: Micallef Jacob Vincent (Chief Scientific Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common | 86166 | Direct |
| Common | 14290 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrant (Right to Buy) | $2.6 | 2016-05-10 | Common Stock (5000) | Indirect | |
| Stock Option (Right to Buy) | $3 | 2016-05-25 | Common Stock (20000) | Indirect | |
| Stock Option (Right to Buy) | $3 | 2016-11-25 | Common Stock (20000) | Indirect | |
| Stock Option (Right to Buy) | $4 | 2017-05-25 | Common Stock (20000) | Indirect | |
| Stock Option (Right to Buy) | $4 | 2017-11-25 | Common Stock (20000) | Indirect | |
| Stock Option (Right to Buy) | $5 | 2018-05-25 | Common Stock (20000) | Indirect | |
| Stock Option (Right to Buy) | $5 | 2018-11-25 | Common Stock (20000) | Indirect | |
| Stock Option (Right to Buy) | $3.01 | 2015-12-13 | Common Stock (50000) | Indirect | |
| Warrant (Right to Buy) | $2.4 | 2018-11-25 | Common Stock (4290) | Indirect | |
| Warrant (Right to Buy) | $2.2 | 2019-02-26 | Common Stock (10000) | Direct | |
| Stock Option (Right to Buy) | $2.5 | 2019-02-18 | Common Stock (65000) | Indirect | |
| Stock Option (Right to Buy) | $3 | 2020-02-18 | Common Stock (65000) | Indirect | |
| Stock Option (Right to Buy) | $4 | 2020-01-23 | Common Stock (55000) | Indirect |
Footnotes
F1: These shares of Common Stock are owned of record by Borlaug Limited, which is a consulting firm. Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over these shares. However, Dr. Micallef disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F2: These options to purchase Common Stock were granted pursuant to the Issuer's 2011 Equity Incentive Plan dated November 17, 2011, and are owned of record by Borlaug Limited, which is a consulting firm. Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over the Common shares issuable to Borlaug Limited upon the exercise of these options. However, Dr. Micallef disclaims beneficial ownership of these Options and Warrants except to the extent of his pecuniary interest therein.
F3: These Common Stock Warrants are owned of record by Borlaug Limited, which is a consulting firm. Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over the Common shares issuable to Borlaug Limited upon the conversion of these Warrants. However, Dr. Micallef disclaims beneficial ownership of these Options and Warrants except to the extent of his pecuniary interest therein.